Cargando…

Repurposing MS immunotherapies for CIDP and other autoimmune neuropathies: unfulfilled promise or efficient strategy?

Despite advances in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and other common autoimmune neuropathies (AN), still-many patients with these diseases do not respond satisfactorily to the available treatments. Repurposing of disease-modifying therapies (DMTs) fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kohle, Felix, Dalakas, Marinos C., Lehmann, Helmar C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810996/ https://www.ncbi.nlm.nih.gov/pubmed/36620728 http://dx.doi.org/10.1177/17562864221137129

Ejemplares similares

Objectivity, practicality, and significance of practice guidelines for the practicing neurologists: What we learnt from consensus criteria in CIDP, Myasthenia Gravis and Inflammatory Myopathies
por: Dalakas, Marinos C.
Publicado: (2023)

CIDP: Analysis of Immunomarkers During COVID-19 mRNA-Vaccination and IVIg-Immunomodulation: An Exploratory Study
por: Svačina, Martin K. R., et al.
Publicado: (2023)

The unfulfilled promises of scorpion insectotoxins
por: Ortiz, Ernesto, et al.
Publicado: (2015)

Global Health Equity – An Unfulfilled Promise
por: Vawda, Yousuf A.
Publicado: (2021)

Oxidative stress and the unfulfilled promises of antioxidant agents
por: Giorgio, Marco
Publicado: (2015)

Hippocrates and prophecies: the unfulfilled promise of prediction rules
por: Martin, Claudio M., et al.
Publicado: (2022)

MRI biomarkers of proximal nerve injury in CIDP
por: Lichtenstein, Thorsten, et al.
Publicado: (2017)

Versorgungssituation von CIDP-Patienten in neun deutschen Zentren des Neuritis Netzes
por: Fisse, Anna Lena, et al.
Publicado: (2022)

Loss of Schwann cell plasticity in chronic inflammatory demyelinating polyneuropathy (CIDP)
por: Joshi, Abhijeet R., et al.
Publicado: (2016)

Bromodomain inhibitors a decade later: a promise unfulfilled?
por: Mita, Monica M., et al.
Publicado: (2020)

EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise
por: Westphal, Manfred, et al.
Publicado: (2017)

Orthopaedic tissue engineering and stem cells – an unfulfilled promise
por: Triffitt, James T.
Publicado: (2021)

Chronic inflammatory demyelinating polyneuropathy (CIDP): change of serum IgG dimer levels during treatment with intravenous immunoglobulins
por: Ritter, Christian, et al.
Publicado: (2015)

Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies
por: Dalakas, Marinos C.
Publicado: (2018)

Autoimmune Neurogenic Dysphagia
por: Stathopoulos, Panos, et al.
Publicado: (2021)

PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise?
por: Bazzichetto, Chiara, et al.
Publicado: (2019)

UNFULFILLED PROMISES OF WORKING IN LATER LIFE OF NEW ZEALAND WOMEN
por: Unson, Christine G
Publicado: (2019)

Checkpoint Inhibitors in Multiple Myeloma: Intriguing Potential and Unfulfilled Promises
por: Alkharabsheh, Omar, et al.
Publicado: (2021)

PI3k Inhibitors in NHL and CLL: An Unfulfilled Promise
por: Bou Zeid, Naji, et al.
Publicado: (2023)

Contributions of molecular biology to antipsychotic drug discovery: promises fulfilled or unfulfilled?
por: Roth, Bryan L.
Publicado: (2006)

Unfulfilled Promise: Pollinator Declines, Crop Deficits, and Diet-Associated Disease
por: Nicole, Wendee
Publicado: (2023)

Guillain-Barré syndrome: The first documented COVID-19–triggered autoimmune neurologic disease: More to come with myositis in the offing
por: Dalakas, Marinos C.
Publicado: (2020)

Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases
por: Stathopoulos, Panos, et al.
Publicado: (2022)

Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy
por: Dalakas, Marinos C.
Publicado: (2021)

IgG4-Mediated Neurologic Autoimmunities: Understanding the Pathogenicity of IgG4, Ineffectiveness of IVIg, and Long-Lasting Benefits of Anti–B Cell Therapies
por: Dalakas, Marinos C.
Publicado: (2021)

Therapeutic Antibodies in Neurological Diseases: Witnessing the Continuation of the Impressive Success in Neuro-Immunotherapies
por: Dalakas, Marinos C., et al.
Publicado: (2022)

Prognostic and Predictive Implications of PTEN in Breast Cancer: Unfulfilled Promises but Intriguing Perspectives
por: Carbognin, Luisa, et al.
Publicado: (2019)

Protecting Public Health through Technology Transfer: The Unfulfilled Promise of the TRIPS Agreement
por: Hoen, Ellen ‘T
Publicado: (2022)

Autoimmune Neurological Disorders with IgG4 Antibodies: a Distinct Disease Spectrum with Unique IgG4 Functions Responding to Anti-B Cell Therapies
por: Dalakas, Marinos C.
Publicado: (2022)

CIDP/autoimmune nodopathies with nephropathy: a case series study
por: Tang, Yuwei, et al.
Publicado: (2023)

The unfulfilled potential of mucosal immunization
por: Baker, James R., et al.
Publicado: (2022)

History Bias, Study Design, and the Unfulfilled Promise of Pay-for-Performance Policies in Health Care
por: Naci, Huseyin, et al.
Publicado: (2016)

Obinutuzumab, a potent anti–B-cell agent, for rituximab-unresponsive IgM anti-MAG neuropathy
por: Rakocevic, Goran, et al.
Publicado: (2018)

Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder
por: Rakocevic, Goran, et al.
Publicado: (2019)

The Unfulfilled Promise of Inhaled Therapy in Ventilator-Associated Infections: Where Do We Go from Here?
por: Palmer, Lucy B., et al.
Publicado: (2022)

Could symptom overlap of COVID-19 and Guillain–Barré syndrome mask an epidemiological association?
por: Svačina, Martin K. R., et al.
Publicado: (2021)

The comparison of MRN, electrophysiology and progression among typical CIDP and atypical CIDP subtypes
por: Feng, Yuan, et al.
Publicado: (2020)

Kinesin-5 inhibition improves neural regeneration in experimental autoimmune neuritis
por: Kohle, Felix, et al.
Publicado: (2023)

Bioresorbable scaffold technology: The yet unfulfilled promise of becoming the workhorse stent in the cardiac catherization laboratory
por: Elabbassi, Wael, et al.
Publicado: (2018)

The importance of FcRn in neuro-immunotherapies: From IgG catabolism, FCGRT gene polymorphisms, IVIg dosing and efficiency to specific FcRn inhibitors
por: Dalakas, Marinos C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dkfudbconnldjqgml9254soli5